Table 4

Coexistence of BCR-ABL1 mutations as compound and polyclonal mutations in separate clones originating from the same patient sample

Patient ID no.Clones with compound mutationClones with first component mutationClones with second component mutation
CML#10 M244V/T315I/I347T/T406I (1/10) M244V (4/10) T315I (2/10) 
CML#11 G250E/M351T/L429P (1/10) G250E/H396R (1/10) M351T (4/10) 
G250E/M351T (1/10) G250E (1/10) M351T/L341P (1/10) 
CML#13 E255K/F317L (1/10) E255K (2/10) F317L (2/10) 
F317L/D391G/E334K (1/10) 
F317L/T389A (1/10) 
CML#23 G250E/T315I (1/10) G250E (8/10) T315I (1/10) 
CML#30 Y253H/F317L (1/10) Y253H (2/10) F317L (4/10) 
CML#31 M244V/F317L (1/8) M244V (3/8) F317L (2/8) 
M244V/D391G (1/8) 
CML#35 Y253H/F359V/A366V (1/10) Y253H (3/10) F359V (3/10) 
Y253H/F359V (2/10) 
CML#37 V299L/F359V (2/10) V299L (2/10) F359V (3/10) 
A288T/ V299L/F359V/W423Stop (1/10) V299L/V377A (1/10) M244T/F359V/ T389A (1/10) 
CML#40 M244V/E459K (1/10) M244V (1/10) E459K (2/10) 
W423R/E459K (1/10) 
K247R/E459K (1/10) 
E238G/L273S/E459K (1/10) 
CML#41 E255K/T315I (8/10) E255K (1/10) T315I (1/10) 
CML#44 L387M/T315I (6/10) L387M (2/10) T315I (2/10) 
CML#50 G250E/E459K (1/9) G250E (1/9) E459K (3/9) 
G250E/F317L (1/9) L266P/E459K (1/9) 
CML#51 F311L/L341P/H396R (1/10) E279G/F311L/E355G/W405R (1/10) H396R (1/10) 
L266P/K356R/H396R (1/10) 
H396R/N414S (1/10) 
Patient ID no.Clones with compound mutationClones with first component mutationClones with second component mutation
CML#10 M244V/T315I/I347T/T406I (1/10) M244V (4/10) T315I (2/10) 
CML#11 G250E/M351T/L429P (1/10) G250E/H396R (1/10) M351T (4/10) 
G250E/M351T (1/10) G250E (1/10) M351T/L341P (1/10) 
CML#13 E255K/F317L (1/10) E255K (2/10) F317L (2/10) 
F317L/D391G/E334K (1/10) 
F317L/T389A (1/10) 
CML#23 G250E/T315I (1/10) G250E (8/10) T315I (1/10) 
CML#30 Y253H/F317L (1/10) Y253H (2/10) F317L (4/10) 
CML#31 M244V/F317L (1/8) M244V (3/8) F317L (2/8) 
M244V/D391G (1/8) 
CML#35 Y253H/F359V/A366V (1/10) Y253H (3/10) F359V (3/10) 
Y253H/F359V (2/10) 
CML#37 V299L/F359V (2/10) V299L (2/10) F359V (3/10) 
A288T/ V299L/F359V/W423Stop (1/10) V299L/V377A (1/10) M244T/F359V/ T389A (1/10) 
CML#40 M244V/E459K (1/10) M244V (1/10) E459K (2/10) 
W423R/E459K (1/10) 
K247R/E459K (1/10) 
E238G/L273S/E459K (1/10) 
CML#41 E255K/T315I (8/10) E255K (1/10) T315I (1/10) 
CML#44 L387M/T315I (6/10) L387M (2/10) T315I (2/10) 
CML#50 G250E/E459K (1/9) G250E (1/9) E459K (3/9) 
G250E/F317L (1/9) L266P/E459K (1/9) 
CML#51 F311L/L341P/H396R (1/10) E279G/F311L/E355G/W405R (1/10) H396R (1/10) 
L266P/K356R/H396R (1/10) 
H396R/N414S (1/10) 

The predominant compound mutations and their components are shown in bold. Silent mutation components are not shown in this table. The frequency of each clone is shown in proportion to the number of sequenced clones per sample.

or Create an Account

Close Modal
Close Modal